Posts by Manisha Bahl, MD, MPH
-
Editorial: Artificial Intelligence May Allow Reduced Use of Gadolinium-based Contrast Agents
Commenting on a German study, Manisha Bahl, MD, MPH, explains how AI can be applied to breast MRI scans acquired with low doses of gadolinium-based contrast agents (GBCAs) and predict the appearance of full-dose contrast-enhanced subtraction images, a potential way to reduce the dose and therefore toxicity of GBCAs.
-
Editorial: Emerging Indications for Contrast-enhanced Mammography
Manisha Bahl, MD, MPH, a radiologist in the Breast Imaging Division in the Department of Radiology, explains the importance of a recent systematic review and meta-analysis that includes all literature published to date on contrast-enhanced mammography.
-
Developing Tools for Active Surveillance Programs for Early-Stage Breast Cancer
An artificial intelligence tool developed by Manisha Bahl, MD, and colleagues identifies patients with low-risk early-stage breast cancer who are appropriate candidates for active surveillance programs, thus helping the patients avoid unnecessary surgery or radiation.
-
Digital Breast Tomosynthesis Superior to Mammography for Surveillance of Breast Cancer Survivors
Manisha Bahl, MD, MPH, and Constance D. Lehman, MD, PhD, of the Department of Radiology, and colleagues found that, among breast cancer survivors, digital breast tomosynthesis was associated with a lower abnormal interpretation rate and higher specificity than conventional mammography.
Biography
Manisha Bahl, MD, MPH, is a radiologist in the Breast Imaging Division of the Department of Radiology at Massachusetts General Hospital and an associate professor of radiology at Harvard Medical School.
Mass General Imaging
For over 100 years, the Department of Radiology at Massachusetts General Hospital has pioneered imaging technology to improve human health. Today, our researchers develop powerful new ways to diagnose and treat many diseases. From the lab to the clinic, our community of radiologists and researchers brings advances directly to our patients.